XML 29 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details)
6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended
Jun. 30, 2012
USD ($)
Dec. 31, 2011
USD ($)
Sep. 30, 2010
Caliper Life Sciences [Member]
USD ($)
sqft
Jun. 30, 2012
Caliper Life Sciences [Member]
USD ($)
Dec. 31, 2011
Caliper Life Sciences [Member]
USD ($)
Dec. 31, 2011
BMR-Gateway Boulevard LLC [Member]
USD ($)
Dec. 31, 2010
BMR-Gateway Boulevard LLC [Member]
USD ($)
sqft
Jun. 30, 2012
BMR-Gateway Boulevard LLC [Member]
USD ($)
sqft
Jun. 30, 2012
Scientific and Administrative Facility [Member]
USD ($)
Dec. 31, 2011
Scientific and Administrative Facility [Member]
USD ($)
Jan. 31, 2011
Stem Cell Sciences UK [Member]
GBP (£)
sqft
Jun. 30, 2012
Stem Cell Sciences UK [Member]
USD ($)
Commitments and Contingencies (Textual) [Abstract]                        
Area of facility     13,200       43,000          
Term of lease     2 years     11 years 6 months     15 years      
Rent over term of lease     $ 1,081,000       $ 17,869,000          
Deferred rent 651 2,603   1,600 2,600 1,301,000   1,350,000 350,000 452,000    
Additional area of facility               30,000        
Area of leased space                     5,000  
Area of lease reduced                     1,900  
Rental payments                     61,000  
Annual payments                       50,000
Useful life 15 years                     14 years
Litigation costs                       700,000
Royalty payments                       650,000
Operating lease payments                 1,172,000      
Cash outlay net of subtenant rent                 1,423,000      
Lease term expires       Sep. 30, 2013         Jun. 30, 2013      
Receipt of sub-tenant income                 439,000      
Commitments and Contingencies (Additional Textual) [Abstract]                        
Proceeds from the issuance of industrial revenue bonds 5,000,000                      
Period of maturity Aug. 01, 2014                      
Interest rate for remaining bond series 9.50%                      
Outstanding principal 430,000 523,000                    
Operating expenses $ 690,000